<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 1997
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
----------- -----------
Commission File Number 0-20905
-------
UNITED PAYORS & UNITED PROVIDERS, INC.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 51-0374698
------------------------------- ---------------------
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification Number)
2275 Research Boulevard, 6th Floor, Rockville, Maryland 20850
--------------------------------------------------------------
(Address of principal executive offices, Zip Code)
(301) 548-1000
------------------------------------------------
(Registrant's phone number, including area code)
Not Applicable
----------------------------------------------------
(Former name, former address and former fiscal year,
if changed since last report)
Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. Yes X No
---
Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the last practicable date.
The number of shares of common stock, par value $.01 per share, outstanding on
July 31, 1997 was 11,511,586.
<PAGE>
UNITED PAYORS & UNITED PROVIDERS, INC.
AND SUBSIDIARIES
SECOND QUARTER 1997 FORM 10-Q
TABLE OF CONTENTS
<TABLE>
<CAPTION>
Page
----
<S> <C>
PART IFINANCIAL INFORMATION
ITEM 1. Financial Statements
Consolidated Balance Sheets as of June 30, 1997 and
December 31, 1996................................................. 1
Consolidated Statements of Operations for the Three and Six Months
Ended June 30, 1997 and 1996..................................... 2
Consolidated Statements of Cash Flows for the Six Months
Ended June 30, 1997 and 1996..................................... 3
Notes to Consolidated Financial Statements............................ 4
ITEM 2. Management's Discussion and Analysis of Financial
Condition and Results of Operations........................... 6
PART II OTHER INFORMATION
SIGNATURES
</TABLE>
<PAGE>
PART I. FINANCIAL INFORMATION
ITEM 1. Financial Statements
UNITED PAYORS & UNITED PROVIDERS, INC.
CONSOLIDATED BALANCE SHEETS
<TABLE>
<CAPTION>
June 30, December 31,
1997 1996
------------ ------------
(Unaudited)
<S> <C> <C>
ASSETS
Current assets:
Cash and cash equivalents $11,219,418 $16,034,184
Short-term investments 11,695,919 10,448,564
Accounts receivable 9,679,016 8,108,015
Deferred income taxes 260,300 342,300
Other current assets 297,288 227,922
----------- -----------
Total current assets 33,151,941 35,160,985
----------- -----------
Fixed assets, net 3,261,817 2,782,601
Advances to contracting providers, net 11,933,009 4,300,730
Investments 1,811,406 1,079,354
Intangible and other assets, net 9,659,215 9,924,253
----------- -----------
Total assets $59,817,388 $53,247,923
=========== ===========
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable and accrued expenses $ 6,140,096 $ 5,758,025
Income and other taxes payable 1,016,571 958,991
Notes payable and capital lease 15,994 330,912
----------- -----------
Total current liabilities 7,172,661 7,047,928
Non-current accrued expense 400,000 700,000
Notes payable and capital lease, less current portion 99,281 324,281
------------ -----------
Total liabilities 7,671,942 8,072,209
----------- -----------
Commitments and contingencies
Stockholders' equity:
Convertible preferred stock, $0.01 par value, 5,000,000 shares
authorized, none issued and outstanding at June 30,
1997 and December 31, 1996 - -
Common stock, $0.01 par value, 35,000,000 shares authorized,
11,573,636 shares issued at June 30, 1997 and
December 31, 1996, respectively 115,736 115,736
Additional paid-in capital 37,086,505 35,154,820
Deferred compensation (1,265,500) -
Retained earnings 16,746,070 9,935,158
Less treasury stock, 47,050 shares at June 30, 1997 and
22,500 shares at December 31, 1996, at cost (537,365) (30,000)
----------- -----------
Total stockholders' equity 52,145,446 45,175,714
----------- -----------
Total liabilities and stockholders' equity $59,817,388 $53,247,923
=========== ===========
</TABLE>
1
<PAGE>
UNITED PAYORS & UNITED PROVIDERS, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
<TABLE>
<CAPTION>
Three Months Ended June 30, Six Months Ended June 30,
1997 1996 1997 1996
----------- ----------- ----------- -----------
<S> <C> <C> <C> <C>
Provider network revenue $ 8,678,057 $ 7,672,866 $17,299,034 $15,083,063
Utilization management 4,951,950 - 9,777,315 -
Other revenue 95,620 74,205 202,066 155,632
----------- ----------- ----------- -----------
Total revenue 13,725,627 7,747,071 27,278,415 15,238,695
----------- ----------- ----------- -----------
Operating expenses:
Direct contract expenses 6,254,235 3,083,132 12,915,916 6,233,710
General and administrative 1,430,063 313,388 3,019,511 644,964
Depreciation and amortization 325,210 78,578 655,797 141,340
----------- ----------- ----------- -----------
Total operating expenses 8,009,508 3,475,098 16,591,224 7,020,014
----------- ----------- ----------- -----------
Operating income 5,716,119 4,271,973 10,687,191 8,218,681
Other income (expense), net 427,365 (5,118) 743,294 130,789
----------- ----------- ----------- -----------
Income before income taxes 6,143,484 4,266,855 11,430,485 8,349,470
Income tax provision (2,482,971) (1,707,000) (4,619,573) (3,340,000)
----------- ----------- ----------- -----------
Net income $ 3,660,513 $ 2,559,855 $ 6,810,912 $ 5,009,470
=========== =========== =========== ===========
Net income per share $ 0.31 $ 0.29 $ 0.58 $0.57
=========== =========== =========== ===========
Shares used in computing net income
per common share outstanding 11,767,745 8,800,000 11,682,098 8,800,000
</TABLE>
2
<PAGE>
UNITED PAYORS & UNITED PROVIDERS, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
<TABLE>
<CAPTION>
Six Months Ended June 30,
1997 1996
------------ -----------
<S> <C> <C>
Operating activities
Net income $ 6,810,912 $ 5,009,470
Adjustment to reconcile net income to
net cash provided by (used in) operations
Depreciation and amortization 655,797 141,340
Loss on sale of fixed assets 143,138 -
Deferred income taxes and other non-cash items 366,048 654,000
Changes in reserves and allowances 66,721 -
Changes in assets and liabilities:
Accounts receivable (1,521,001) (4,372,021)
Accounts payable and accrued expenses 274,071 (962,653)
Current and other assets (90,286) (322,805)
Income taxes payable 57,580 1,247,364
------------ -----------
Net cash provided by (used in) operating activities 6,762,980 1,394,695
------------ -----------
Investing activities
Purchases of fixed assets (1,121,231) (395,123)
Proceeds from sale of fixed assets 37,038 -
Purchases of short-term investments (12,408,326) -
Proceeds from sale of short-term investments 11,393,108 -
Advances to contracting providers (7,699,000) (227,000)
Payments for investments (732,052) (40,712)
------------ -----------
Net cash used in investing activities (10,530,463) (662,835)
------------ -----------
Financing activities
Purchases of treasury stock (507,365) -
Repayment of loan from stockholder - (3,700,000)
Deferred public offering costs - (739,680)
Repayment of other debt (539,918) (14,060)
------------ -----------
Net cash used in financing activities (1,047,283) (4,453,740)
------------ -----------
Decrease in cash and cash equivalents (4,814,766) (3,721,880)
Cash and cash equivalents
Beginning of the period 16,034,184 8,701,135
------------ -----------
End of the period $ 11,219,418 $ 4,979,255
============ ===========
</TABLE>
3
<PAGE>
UNITED PAYORS & UNITED PROVIDERS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
1. BUSINESS, ORGANIZATION AND BASIS OF PRESENTATION
United Payors & United Providers, Inc. ("UP&UP"), a Delaware corporation,
was originally incorporated in the State of Iowa on January 3, 1995 as PB Newco,
Inc. Effective June 7, 1996, PB Newco, Inc. was merged into UP&UP with UP&UP
being the surviving corporation. UP&UP serves as an intermediary between health
care payors (e.g., insurance companies) and health care providers (e.g.,
hospitals) by entering into contractual arrangements designed generally to
produce cost savings and other benefits for payors and increased liquidity and
improved efficiency in claims submissions for providers. UP&UP derives its
revenue primarily from a portion of the price concessions offered by the
providers under such contractual arrangements. Effective October 1, 1996, the
Company acquired National Health Services, Inc. ("NHS"), a national health care
utilization management services company. Through NHS, the Company offers medical
utilization management services to insurance underwriters, self-insured
businesses, provider organizations, and others. Such services include
precertification of in-patient and out-patient medical care, and case
management.
In connection with the June 7, 1996 merger, the Company effected a 10:1
exchange of common stock and an increase in authorized shares of capital stock
to 40,000,000 shares, of which 35,000,000 shares were common stock and 5,000,000
shares were preferred stock.
2. INITIAL PUBLIC OFFERING
The Company filed a Registration Statement on Form S-1 with the Securities
and Exchange Commission which offered to the public 2,400,000 shares (2,760,000
shares, including the overallotment) of the Company's common stock. This
registration statement was declared effective on June 28, 1996.
The closings of the sale of stock were effected on July 8, 1996 and July 15,
1996 for which the Company received proceeds (net of underwriters' commissions
and expenses) of $23.4 million and $3.5 million, respectively.
3. LEGAL PROCEEDINGS
Except as discussed below, the Company currently is not a party to any legal
proceedings, nor is it aware of any legal proceedings threatened against it. On
April 26, 1996, a civil complaint was filed against the Company in the United
States District Court for the Northern District of Illinois by HealthCare
COMPARE Corporation d/b/a The Affordable Medical Networks ("HealthCare
COMPARE"). The litigation is currently in the discovery phase. HealthCare
COMPARE seeks injunctive and other relief, including possible damages, based
generally on allegations that representatives of the Company, in at least four
instances, made various misrepresentations to prospective contracting providers,
including to the effect that the Company's provider network was affiliated with
HealthCare COMPARE's provider network or that HealthCare COMPARE had agreed to
utilize the Company's provider network. The Company denies the allegations in
the complaint and believes the complaint by HealthCare COMPARE is without merit.
The Company intends to vigorously defend against the complaint. After
consultation with counsel and review of available facts, management believes
that damages, if any, arising from litigation will not be material to the
consolidated financial statements of the Company. The Company is also a party to
other legal actions arising in the ordinary course of business. Management
believes that damages arising from these actions, if any, will not be material
to the consolidated financial statements of the Company.
4
<PAGE>
4. BUSINESS COMBINATION
Effective October 1, 1996, the Company acquired National Health Services,
Inc. for a purchase price of approximately $7.2 million, consisting of $5.9
million in cash, warrants to purchase an aggregate of 318,000 shares of the
Company's common stock valued at $1.1 million and the assumption of
approximately $200,000 in liabilities in excess of the fair market value of the
assets acquired. NHS is a national health care management services company. The
acquisition has been accounted for as a purchase and, accordingly, the results
of operations of NHS for the three and six months ended June 30, 1996 have not
been included in the accompanying consolidated statements of operations of the
Company for those periods. The acquisition resulted in goodwill of $7.2 million
which is being amortized over 15 years. Accumulated amortization at June 30,
1997 amounted to $361,323. The unamortized portion of the goodwill at June 30,
1997, is included in intangible and other assets in the accompanying
consolidated balance sheet.
5. RECLASSIFICATIONS
Certain amounts in the financial statements for the quarters ended June 30,
1996 and March 31, 1997 have been reclassified to conform to the presentation of
the financial statements for the quarter ended June 30, 1997.
6. EARNINGS PER SHARE
In February 1997, the Financial Accounting Standards Board issued Statement
of Financial Accounting Standards No. 128, "Earnings Per Share", effective for
financial statements for both interim and annual periods ending after December
15, 1997. This Statement replaces the existing calculation and presentation of
primary and fully diluted earnings per share with basic and diluted earnings per
share. This change is not expected to have a material effect on the Company's
earnings per share.
7. UNAUDITED INFORMATION
The consolidated financial statements for the three and six months ended
June 30, 1997 and 1996 have not been audited but, in the opinion of management,
include all adjustments (consisting only of normal recurring accruals) necessary
to present fairly the information set forth therein. The results of operations
for the three and six months ended June 30, 1997 and 1996 are not necessarily
indicative of the results to be expected for the full year or in the future.
5
<PAGE>
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS
This Form 10-Q may contain forward-looking statements (see "Certain Factors
That May Affect Future Operating Results or Stock Prices") within the meaning of
Section 21E of the Securities Exchange Act of 1934, as amended. These forward-
looking statements involve a number of risks and uncertainties. The Company
undertakes no obligation to revise any forward-looking statements in order to
reflect events or circumstances that may arise after the date of this report.
Readers are urged to carefully review and consider the various disclosures made
by the Company in this report and in the Company's other filings with the
Securities and Exchange Commission that attempt to advise interested parties of
the risks and factors that may affect the Company's business.
GENERAL
United Payors & United Providers, Inc. ("UP&UP"), a Delaware corporation,
was originally incorporated in the State of Iowa on January 3, 1995 as PB Newco,
Inc. Effective June 7, 1996, PB Newco, Inc. was merged into UP&UP with UP&UP
being the surviving corporation. UP&UP serves as an intermediary between health
care payors (e.g., insurance companies) and health care providers (e.g.,
hospitals) by entering into contractual arrangements designed generally to
produce cost savings and other benefits for payors ("Payor Clients") and
increased liquidity and improved efficiency in claims submissions for providers
("Contracting Providers"). UP&UP derives its revenue primarily from a portion of
the price concessions offered by the providers under such contractual
arrangements. Effective October 1, 1996, the Company acquired National Health
Services, Inc. ("NHS"), a national health care utilization management services
company. Through NHS, the Company offers medical utilization management services
to insurance underwriters, self-insured businesses, provider organizations, and
others. Such services include precertification of in-patient and out-patient
medical care, and case management. The acquisition has been accounted for as a
purchase and, accordingly, the consolidated results of operations of the Company
for the three and six months ended June 30, 1996 do not include the results of
operations of NHS for those periods.
In connection with the June 7, 1996 merger, the Company effected a 10:1
exchange of common stock and an increase in authorized shares of capital stock
to 40,000,000 shares, of which 35,000,000 shares were common stock and 5,000,000
shares were preferred stock.
REVENUE
Provider network revenues are influenced by, among other variables: (i) the
number of Contracting Providers and Payor Clients; (ii) the volume of claims
submitted by Contracting Providers to Payor Clients; (iii) the amount of price
concessions the Company negotiates with Contracting Providers; and (iv) the
contractual price concession sharing arrangements negotiated by the Company with
Payor Clients. In effect, these variables correspond to breadth (number of
Contracting Providers and Payor Clients), volume (claims per period) and depth
(amount of price concession), all of which define savings and the Company's
resultant revenues.
Medical utilization management services revenues are based on contractual
arrangements. Contracts may reflect a capitated rate, fee for service or hourly
rate. Precertification revenues are generally based on monthly capitation
calculations. Case management revenues are generally based on fee for service or
hourly rates.
DIRECT CONTRACT EXPENSES
Direct contract expenses include access fees paid by the Company for the
utilization of other provider networks, marketing commissions, and other direct
costs of services such as personnel related to repricing of claims, client
services, and other costs incurred in connection with the generation of revenue
and the development of the UP&UP Network. NHS direct contract expenses include
the costs of medical personnel (nurses and doctors) and other expenses related
to administering its contracts.
6
<PAGE>
The Company accesses certain other networks of medical providers, including
the provider network organized and maintained by America's Health Plan, Inc.
("AHP"), an indirect wholly-owned subsidiary of Principal Mutual Life Insurance
Company, an affiliate and founding shareholder. The level of network access fees
as a percentage of provider network revenue is expected to decrease as a result
of the continued expansion of the Company's direct network. Marketing
commissions are payable to consultants who became entitled to such commissions
for their role in obtaining contracts with certain Payor Clients. Generally,
these marketing commissions are based on a percentage of the revenue generated
by the Payor Client.
GENERAL AND ADMINISTRATIVE EXPENSES
General and administrative expenses include salaries and related costs for
personnel involved in the administration of the Company and other costs such as
professional services and general overhead expenses.
RESULTS OF OPERATIONS
Three Months Ended June 30, 1997 Compared to Three Months Ended June 30, 1996
Provider network revenue increased by $1.0 million, from $7.7 million in
1996 to $8.7 million in 1997. This increase was attributable to the addition of
new Payor Clients, the growth in the overall claims volume from existing Payor
Clients and the expansion of the Company's provider network. At June 30, 1997
the provider network consisted of approximately 4,400 Contracting Providers
compared to approximately 1,300 Contracting Providers at June 30, 1996.
Utilization management services revenue of $5.0 million in 1997 represents the
revenue of NHS which was acquired effective October 1, 1996.
Direct contract expenses increased by $3.2 million, from $3.1 million in
1996 to $6.3 million in 1997. Access fees to other provider networks as a
percentage of provider network revenue were 19.9% ($1.5 million) in 1996
compared to 13.0% ($1.1 million) in 1997. This decrease was attributable to the
growth in the number of providers contracting directly with the Company, Payor
Clients accessing more direct contracts and the negotiation of lower rates in
agreements with other provider networks. Other direct costs of services
increased approximately $3.5 million, from $1.3 million in 1996 to $4.8 million
in 1997. Of this increase, approximately $3.0 million represented expenses of
NHS which was acquired effective October 1, 1996. The remainder of the increase
was attributable to an overall increase in expenses resulting primarily from a
significant increase in the number of employees to accommodate growth in the
provider network business, increased provider network development activities and
the development of new businesses. Excluding NHS employees, the Company employed
102 employees at June 30, 1997, compared to 46 employees at June 30, 1996.
General and administrative expenses increased approximately $1.1 million,
from approximately $313,000 in 1996 to approximately $1.4 million in 1997. Of
this increase, approximately $545,000 represented expenses of NHS which was
acquired effective October 1, 1996. The remainder of the increase was
attributable to an overall increase in expenses resulting from the addition of
employees in the administrative and executive areas, expenses related to bonus
and other benefit programs which became effective subsequent to the initial
public offering and an increase in professional fees for accounting and legal
services.
Depreciation and amortization increased approximately $246,000 from
approximately $79,000 in 1996 to approximately $325,000 in 1997. The increase
was primarily attributable to the depreciation expense and amortization of
goodwill of NHS.
Six Months Ended June 30, 1997 Compared to Six Months Ended June 30, 1996
Provider network revenue increased by $2.2 million, from $15.1 million in
1996 to $17.3 million in 1997. This increase was attributable to the addition of
new Payor Clients, the growth in the overall claims volume from existing Payor
Clients and the expansion of the Company's provider network. At June 30, 1997
the provider network consisted
7
<PAGE>
of approximately 4,400 Contracting Providers compared to approximately 1,300
Contracting Providers at June 30, 1996. Utilization management services revenue
of $9.8 million in 1997 represents the revenue of NHS which was acquired
effective October 1, 1996.
Direct contract expenses increased by $6.7 million, from $6.2 million in
1996 to $12.9 million in 1997. Access fees to other provider networks as a
percentage of provider network revenue were 19.4% ($2.9 million) in 1996
compared to 13.6% ($2.4 million) in 1997. This decrease was attributable to the
growth in the number of providers contracting directly with the Company, Payor
Clients accessing more direct contracts and the negotiation of lower rates in
agreements with other provider networks. Other direct costs of services
increased approximately $7.4 million, from $2.6 million in 1996 to $10.0 million
in 1997. Of this increase, approximately $6.1 million represented expenses of
NHS which was acquired effective October 1, 1996. The remainder of the increase
was attributable to an overall increase in expenses resulting primarily from a
significant increase in the number of employees to accommodate growth in the
provider network business, increased provider network development activities and
the development of new businesses. Excluding NHS employees, the Company employed
102 employees at June 30, 1997, compared to 46 employees at June 30, 1996.
General and administrative expenses increased approximately $2.4 million,
from approximately $645,000 in 1996 to approximately $3.0 million in 1997. Of
this increase, approximately $1.1 million represented expenses of NHS which was
acquired effective October 1, 1996. The remainder of the increase was
attributable to an overall increase in expenses resulting from the addition of
employees in the administrative and executive areas, expenses related to bonus
and other benefit programs which became effective subsequent to the initial
public offering and an increase in professional fees for accounting and legal
services.
Depreciation and amortization increased approximately $515,000 from
approximately $141,000 in 1996 to approximately $656,000 in 1997. The increase
was primarily attributable to the depreciation expense and amortization of
goodwill of NHS.
LIQUIDITY AND CAPITAL RESOURCES
During the first six months of 1996, the Company financed its operations
principally through equity contributions. In July 1996, the Company completed
the sale to the public of 2,760,000 shares of the Company's common stock and
received proceeds (net of underwriters' commissions and expenses) of
approximately $26.9 million. At June 30, 1997 the Company had working capital of
approximately $26.0 million. In March 1997, the Company entered into two lines
of credit arrangements for loan commitments totaling $15 million. In addition,
the Company has also received a standby commitment for an additional $10
million.
The Company's primary capital resources commitment is to fund payments due
upon exercise of Prepayment Options granted to Contracting Providers. Depending
on increases in claims volume and in the number of Contracting Providers and
Payor Clients, the Company estimates that $7 million to $10 million could be
required to fund Prepayment Options during the remainder of 1997. During June
1997, the Board of Directors of the Company approved a common stock repurchase
program of up to $5 million.
The Company believes that its existing liquidity sources, anticipated funds
from operations, and credit arrangements will satisfy its cash requirements for
the next 36 months. However, in the event that the payment of Prepayment Options
exceeds the Company's currently anticipated estimates and/or other available
sources of liquidity to fund such payments are not as great as anticipated, the
Company could seek to borrow additional funds or obtain additional infusions of
equity to fund the balance of such payments.
IMPACT OF INFLATION
Since the Company's revenues are based on medical costs, the impact of
inflation on operating costs and expenses should be offset by the impact of
inflation of medical costs.
8
<PAGE>
CERTAIN FACTORS THAT MAY AFFECT FUTURE OPERATING RESULTS OR STOCK PRICES
The Company's business is dependent on a variety of factors, including its
ability to enter into contracts with payors and providers on terms attractive to
all parties and the absence of substantial changes in the health care industry
that would diminish the need for the services offered by the Company.
A significant portion of the Company's revenue is derived from a small
number of Payor Clients and state governments. The duration of the Company's
contracts with its Payor Clients and state governments are generally for a one
to two-year period, with automatic renewals on the anniversary date. However,
certain contracts may be terminated by either party at any time, generally upon
90 days notice and at the convenience of the state governments. Such contracts
are also subject to fee negotiations and revisions on an annual basis. There can
be no assurance that any of the Company's contracts with Payor Clients will not
be terminated early or will be renewed, and, if renewed, will contain favorable
terms. The loss of a contract with a major Payor Client and the inability to
replace any such client with significant new clients could have a material
adverse effect on the Company's business, financial condition or results of
operations. During October 1996, Wellpoint Health Networks, Inc. announced the
acquisition of the health insurance business of one of the Company's clients,
John Hancock Mutual Life Insurance Company. During May 1997, Conseco, Inc.
completed its merger with Pioneer Financial Services, Inc., also one of the
Company's clients. The Company has not been advised of and does not anticipate
any changes, at least in the short term, in its contracts with these clients.
The Company's standard contract with a Contracting Provider includes a one-
year term, renewable automatically for successive one-year terms, unless the
Contracting Provider gives written notice of termination, typically at least 90
days prior to the renewal date. These contracts are also subject to negotiation
and revisions on an annual basis with respect to the level and amount of price
concessions for medical services. The termination of a significant number of
contracts with Contracting Providers having a high volume of claims with the
Company's Payor Clients, the inability to replace such contracts with contracts
with similar Contracting Providers and/or the renegotiation of contracts
resulting in reduced price concessions could have a material adverse effect on
the Company. A number of health care providers and/or hospital systems are
merging with or acquiring other hospitals or hospital systems to create large
integrated delivery systems. The formation of these delivery systems may impact
the future ability of the Company to contract directly with the individual
hospital facilities or obtain price concessions at the same level currently
obtained.
Under the Company's agreement with AHP certain Payor Clients have continued
to access other provider networks with which AHP currently has contractual
relationships. These Payor Clients may not have continuing access to certain
providers. The Company is focusing its contracting efforts on replacing these
providers either through direct contracts or by contracting with other provider
networks.
Certain interest groups within the health care industry have expressed
concern with certain activities of entities that have been referred to as
"Silent PPOs." The Company understands that some provider-sponsored professional
or trade associations may be considering a legal challenge against one or more
such organizations, and that regulatory agencies in certain states may be
investigating the activities of such organizations. Although it is unclear what
legal theories would support such a challenge or warrant such an investigation,
there can be no assurance that the Company would not be a target of such
challenge or investigation.
The potential impact of all of the above factors is difficult for the
Company to forecast, and these or other factors, such as sales of substantial
amounts of the Company's Common Stock in the public market, the Company's common
stock repurchase program, and changes in earnings estimates by securities
analysts, can materially affect the Company's operating results and stock price.
Further, in recent years, the stock market has experienced extreme price and
volume fluctuations that have particularly affected the market prices of
securities of many companies, for reasons frequently unrelated to the
performance of the specific companies. These fluctuations, as well as general
economic, political and market conditions, may materially adversely affect the
market price of the Company's Common Stock. There can be no assurances that the
trading price of the Company's Common Stock will remain at or near its current
level.
9
<PAGE>
PART II. OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
Neither the Company nor its subsidiaries are involved in any pending legal
proceedings, other than routine legal matters occurring in the ordinary course
of business, which in the aggregate involve amounts which are believed by
management to be immaterial to the consolidated financial condition or results
of operations of the Company, except as referenced in Note 3 to the Consolidated
Financial Statements for the three and six months ended June 30, 1997.
ITEM 2. CHANGES IN SECURITIES (Not Applicable)
ITEM 3. DEFAULTS UPON SENIOR SECURITIES (Not Applicable)
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
The annual meeting of the stockholders of the Company was held on June 3,
1997. The following matters were submitted to a vote of the stockholders:
1. The following individuals were elected to the Board of Directors for a three-
year term with the indicated votes:
<TABLE>
<CAPTION>
For Against Abstain
---------- ------- -------
<S> <C> <C> <C>
William E. Brock 10,901,856 2,550 None
Edward S. Civera 10,901,856 2,550 None
David J. Drury 10,901,856 2,550 None
</TABLE>
The following individual was elected to the Board of Directors for a one-
year term with the indicated votes:
<TABLE>
<CAPTION>
For Against Abstain
---------- ------- -------
<S> <C> <C> <C>
Kenneth J. Linde 10,901,706 2,700 None
</TABLE>
Board members whose term of office continued after the meeting are as
follows:
Bette B. Anderson
Thomas L. Blair
Frederick H. Graefe
Thomas J. Graf
Julia Lawler
2. The adoption of the Company's 1996 Employee Stock Purchase Plan was approved
by a count of 10,611,489 affirmative votes, 16,600 negative votes and 6,390
abstentions.
3. The adoption of the Company's 1996 Stock Option Plan was approved by a count
of 8,948,779 affirmative votes, 1,666,610 negative votes and 7,690
abstentions.
4. The appointment of Coopers & Lybrand L.L.P. as independent auditors of the
Company was ratified by a count of 10,791,266 affirmative votes, 950
negative votes and 4,790 abstentions.
There were 269,927 and 281,327 broker non-votes with respect to the adoption
of the Company's 1996 Employee Stock Purchase Plan and the 1996 Stock Option
Plan, respectively.
ITEM 5. OTHER INFORMATION (None)
10
<PAGE>
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K
1. The following exhibits are filed as part of this report unless noted
otherwise:
Exhibit No. Description
----------- -----------
2.1 Agreement with America's Health Plan, Inc.*
2.2 Plan and Agreement of Merger of IM&I, Inc. into PB Newco*
2.3 Plan and Agreement of Merger of PB Newco, Inc. into United
Payors & United Providers, Inc.*
3.1 Certificate of Incorporation of United Payors & United
Providers, Inc.*
3.2 Bylaws of United Payors & United Providers, Inc.*
4.1 Specimen Stock Certificate of United Payors & United Providers,
Inc.*
4.2 Shareholder Agreement*
10.1 Employment Agreement between United Payors & United Providers,
Inc. and Thomas L. Blair *
10.2 Employment Agreements between United Payors & United Providers,
Inc. and each of Spiro A. Karadimas, S. Joseph Bruno and Michael
A. Smith*
10.3 Form of Indemnification Agreement*
10.4 Stock Purchase Agreement between Preferred Health Choice and
United Payors & United Providers, Inc. dated October 22, 1996**
10.5 Warrants to Purchase 150,000 Shares of Common Stock of United
Payors & United Providers, Inc. Issued to Preferred Health
Choice, Inc. dated October 23, 1996***
10.6 Warrants to Purchase 168,000 Shares of Common Stock of United
Payors & United Providers, Inc. Issued to Preferred Health
choice, Inc. dated October 27, 1996***
11.1 Statement Regarding Computation of Earnings Per Common Share--
Three Months
11.2 Statement Regarding Computation of Earnings Per Common Share--
Six Months
27.1 Financial Data Schedule
2. Reports on Form 8-K (None)
- ---------------
* Incorporated herein by reference into this document from the Exhibits to
the Form S-1 Registration Statement as amended, Registration No. 333-3814,
initially filed on April 19, 1996.
** Incorporated herein by reference into this document from the Exhibits to
the Form 10-Q for the quarter ended September 30, 1996.
*** Incorporated herein by reference into this document from the Exhibits A-1
and A-2 to the Stock Purchase Agreement filed as Exhibit 10.4 to the Form 10-Q
for the quarter ended September 30, 1996.
11
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
UNITED PAYORS & UNITED PROVIDERS, INC.
(Registrant)
Date: August 13, 1997 By: /s/ THOMAS L. BLAIR
------------------------------------------
Thomas L. Blair
Chairman and Chief Executive Officer
Date: August 13, 1997 By: /s/ EDWARD S. CIVERA
------------------------------------------
Edward S. Civera
President and Chief Operating Officer
Date: August 13, 1997 By: /s/ S. JOSEPH BRUNO
------------------------------------------
S. Joseph Bruno
Vice President and Chief Financial Officer
Date: August 13, 1997 By: /s/ EDUARDO V. FEITO
-----------------------------------------
Eduardo V. Feito
Controller and Chief Accounting Officer
12
<PAGE>
EXHIBIT 11.1
UNITED PAYORS & UNITED PROVIDERS, INC.
AND SUBSIDIARIES
COMPUTATION OF EARNINGS PER COMMON SHARE
(Unaudited)
<TABLE>
<CAPTION>
Three Months Ended June 30,
1997 1996
------------- ----------
<S> <C> <C>
PRIMARY
Net income $ 3,660,513 $2,559,855
=========== ==========
Weighted average number of common shares outstanding:
Shares outstanding from beginning of period 11,558,436 8,800,000
Other issuances of common stock - -
Purchases of treasury stock (3,443) -
Common stock equivalents:
Additional equivalent shares issuable from assumed
exercise of common stock options 212,752 -
----------- ----------
Weighted average common and common share equivalents 11,767,745 8,800,000
=========== ==========
Net income per common share $ 0.31 $ 0.29
=========== ==========
FULLY DILUTED
Net income $ 3,660,513 $2,559,855
=========== ==========
Weighted average number of common shares outstanding:
Shares outstanding from beginning of period 11,558,436 8,800,000
Other issuances of common stock - -
Purchases of treasury stock (3,443) -
Common stock equivalents:
Additional equivalent shares issuable from assumed
exercise of common stock options 229,449 -
----------- ----------
Weighted average common and common share equivalents 11,784,442 8,800,000
=========== ==========
Net income per common share $ 0.31 $ 0.29
=========== ==========
</TABLE>
<PAGE>
EXHIBIT 11.2
UNITED PAYORS & UNITED PROVIDERS, INC.
AND SUBSIDIARIES
COMPUTATION OF EARNINGS PER COMMON SHARE
(Unaudited)
<TABLE>
<CAPTION>
Six Months Ended June 30,
1997 1996
------------ ------------
<S> <C> <C>
PRIMARY
Net income $ 6,810,912 $5,009,470
=========== ==========
Weighted average number of common shares outstanding:
Shares outstanding from beginning of period 11,551,136 8,800,000
Other issuances of common stock 13,261 -
Purchases of treasury stock (6,148) -
Common stock equivalents:
Additional equivalent shares issuable from assumed
exercise of common stock options 123,849 -
----------- ----------
Weighted average common and common share equivalents 11,682,098 8,800,000
=========== ==========
Net income per common share $ 0.58 $ 0.57
=========== ==========
FULLY DILUTED
Net income $ 6,810,912 $5,009,470
=========== ==========
Weighted average number of common shares outstanding:
Shares outstanding from beginning of period 11,551,136 8,800,000
Other issuances of common stock 13,261 -
Purchases of treasury stock (6,148) -
Common stock equivalents:
Additional equivalent shares issuable from assumed
exercise of common stock options 147,898 -
----------- ----------
Weighted average common and common share equivalents 11,706,147 8,800,000
=========== ==========
Net income per common share $ 0.58 $ 0.57
=========== ==========
</TABLE>
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
Consolidated Balance Sheets and Statements of Operations of United Payors &
United Providers, Inc. as of and for the six months ended June 30, 1997 and is
qualified in its entirety by reference to such financial statements.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-1997
<PERIOD-START> JAN-01-1997
<PERIOD-END> JUN-30-1997
<CASH> 11,219,418
<SECURITIES> 11,695,919
<RECEIVABLES> 9,679,016
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 33,151,941
<PP&E> 4,172,967
<DEPRECIATION> 911,150
<TOTAL-ASSETS> 59,817,388
<CURRENT-LIABILITIES> 7,172,661
<BONDS> 0
0
0
<COMMON> 35,399,376
<OTHER-SE> 16,746,070
<TOTAL-LIABILITY-AND-EQUITY> 59,817,388
<SALES> 0
<TOTAL-REVENUES> 27,278,415
<CGS> 0
<TOTAL-COSTS> 16,591,224
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 16,350
<INCOME-PRETAX> 11,430,485
<INCOME-TAX> 4,619,573
<INCOME-CONTINUING> 6,810,912
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 6,810,912
<EPS-PRIMARY> 0.58
<EPS-DILUTED> 0
</TABLE>